Zydus Therapeutics
Manufacturing · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
73 Route 31 N, Pennington, New Jersey, 0...Website
www.zydustx.comRevenue
<$5 MillionIndustry
About Zydus Therapeutics
Zydus Therapeutics is a clinical stage bio-pharmaceutical company dedicated to developing transformative treatments for rare and serious liver diseases. As a subsidiary of Zydus Lifesciences, it leverages the expertise of 1,300 researchers to innovate new medicines. The company is currently conducting late-stage clinical trials and aims to empower patients with healthier lives through quality healthcare solutions. Their recent achievements include receiving Fast Track Designation from the USFDA for their treatment of Primary Biliary Cholangitis.Explore more
Zydus Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Zydus Therapeutics
Compare insights from companies similar to Zydus Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Zydus Therapeutics
<$5M
11-50
Private
-
2021
VC
Victoria CareySenior Vice President, Commercial Strategy & Analytics
Zydus Therapeutics Tech Stack
A closer look at the technologies used by Zydus Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Zydus Therapeutics
Sign Up For FreeTo access detailed company insights
Zydus Therapeutics is a clinical stage bio-pharmaceutical company dedicated to developing transformative treatments for rare and serious liver diseases. As a subsidiary of Zydus Lifesciences, it leverages the expertise of 1,300 researchers to innovate new medicines. The company is currently conducting late-stage clinical trials and aims to empower... Read More
